Sublime
An inspiration engine for ideas
Each quarter we identify major catalyst events 🥳
⇒ Likely to move the stock +/- by > 20% 📈 📉
$URGN UGN-102
$LPCN Brexanolone
$FGEN Pamrevlumab
$CTXR Mino-Lok
$MRNS Ganaxolone
Access our FREE Big Mover Report!... See more
BiopharmIQ by Ampx.comAtlas Venture 2021 Year In Review
Here's our "state of the industry" talk (that we just shared with our LP's at our Annual Meeting) exploring the macro issues & broader sector, diving into the biotech VC ecosystem, and providing a brief update on Atlas.
https://t.co/IoQ6YfDsf1
Bruce Boothx.com#federatedlearning #drugdiscovery #structuralbiology #openfold3 | Robin Roehm | 18 comments
linkedin.com
Genflow
I'm trying to keep up with the progress of small molecule AI-based drug development. There isn't a fully approved drug yet, so this is a pretty important and engaging race.
I made the below clinical landscape figure today based on some of my notes. I'm only including targets and indications for simplicity.... See more
BioAI hit a data wall 🧱BaseData tries to shatter it 💥
9.8 B 🧬 protein sequences + >1 M 🦠 unseen species, gathered with enforceable benefit-sharing 🤝, expand known diversity >10× 🌍
Next-gen bio-FMs just got rocket fuel 🚀
My junior year of college I had a summer internship at Elliott (incredible experience and everyone there was so gracious with their time) and all of the interns (I think it was 8 of us) had to pitch an equity to a PM.
Had been trading in and out of biopharma / biotech during college so had a baseline familiarity with... See more
Marcus Milionex.com
Longevity Biotech Landscape — Ada Nguyen
adanguyenx.com